Zobrazeno 1 - 5
of 5
pro vyhledávání: '"O Yu Kolotik-Kameneva"'
Publikováno v:
Терапевтический архив, Vol 88, Iss 5, Pp 55-61 (2016)
Aim. To evaluate the impact of incorporating cytoflavin in a treatment regimen for patients with different stages of hypertensive disease (HD). Subjects and methods. The results of treatment were analyzed in 140 patients with HD (53 with Stage I, 50
Externí odkaz:
https://doaj.org/article/8f3169eec4ba46398336ed9ed89d3d99
Publikováno v:
Антибиотики и Химиотерапия, Vol 59, Iss 7-8, Pp 30-36 (2020)
One hundred forty patients (the average age of 46.7±7.7 years) with hypertensive encephalopathy (HE) were observed. 74 patients of the main group received Cytoflavin® in a dose of 2 tablets twise a day in the standard basic therapy. 66 patients of
Externí odkaz:
https://doaj.org/article/d3b97152bb724fb797959e0a9646a89a
Autor:
Chichanovskaya Lv, D. V. Burenichev, O Yu Kolotik-Kameneva, M. A. Sherman, V V Mashin, V A Stupin, Kovalenko Al, S. A. Rumyantseva, E. A. Zhilina, K. V. Golikov, L. A. Belova, Nazarov Mv, M. V. Sal’nikov, Ekaterina Vladimirovna Silina, E. N. Kabaeva, Tsukurova La, N. K. Mazina
Publikováno v:
Neuroscience and Behavioral Physiology. 47:288-295
Objective. To assess antioxidant therapy (ascorbic acid (AA), Cytoflavin) prescribed as part of the standard treatment scheme based on clinical and morphological data in cerebral infarct. Materials and methods. The study was performed from 2010 to 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c15d872311d6979b36ba1891d83643b8
https://doi.org/10.1007/s11055-017-0395-1
https://doi.org/10.1007/s11055-017-0395-1
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 117(7)
To study an influence of cytoflavin therapy on the cerebral hemodynamics in patients with various stages of hypertensive disease (HD).One hundred and forty patients with HD, I-III stages, were randomized into 2 groups: patients of group 1 received co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35b0aaf1cffcf56b8141d83d1af3e923
https://pubmed.ncbi.nlm.nih.gov/28805757
https://pubmed.ncbi.nlm.nih.gov/28805757
Publikováno v:
Терапевтический архив, Vol 88, Iss 5, Pp 55-61 (2016)
To evaluate the impact of incorporating cytoflavin in a treatment regimen for patients with different stages of hypertensive disease (HD).The results of treatment were analyzed in 140 patients with HD (53 with Stage I, 50 with Stage II, and 37 with S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a5ff2a1edb800b717eb974a76ebc8c
https://pubmed.ncbi.nlm.nih.gov/27239928
https://pubmed.ncbi.nlm.nih.gov/27239928